Meeting Program

15:00 – 15:15 Opening & Welcome 

  • Igor Aurer (Croatia)
  • Hermann Einsele (Germany)
  • Raúl Córdoba (Spain) 

15:15 – 16:45 Session 1: Aging, the immune system and lymphomas 

Chair: Raúl Córdoba (Spain) 

  • Biology of aging
    Speaker to be announced
  • Immune senescence
    Alessandra Tucci (Italy)
  • Lymphoma in the elderly
    Raul Cordoba (Spain)
  • Which outcomes really matter to the elderly lymphoma patient
    Speaker to be announced 

16:45 – 17:00 Coffee break  

17:00 – 18:30 Workshop 1: Geriatric assessment 

  • Chair & speaker: Stefano Luminari (Italy)

17:00 – 18:30 Workshop 2: PRO and QoL assessment 

  • Chair & speaker: Raúl Córdoba (Spain) 

18:30 – 19:15 Satellite symposium 1 

19:15 – 20:15 Welcome Reception + Poster session 

09:00 – 10:30 Session 2: Lymphoma and the elderly 

Chair: Igor Aurer (Croatia) 

  • Hodgkin lymphoma – Are there differences between young and elderly
    Jan M Zaucha (Poland)
  • Primary CNS lymphoma in patients unfit for high-dose chemotherapy
    Speaker to be announced
  • Mantle cell lymphoma – Time for new definitions of fit and unfit?
    Speaker to be announced
  • CAR T-cell therapy in elderly patients
    Speaker to be announced  

10:30 – 10:45 Coffee break  

10:45 – 11:45 Panel discussion: Infectious toxicities of immunotherapy 

Chair to be announced 

Panelists

  • Igor Aurer (Croatia)
  • Speaker to be announced
  • Speaker to be announced 

11:45 – 12:30 Lunch break  

12:00 – 13:00 Satellite Symposium  

13:00 – 14:00 Oral Session 1  

14:00 – 15:30 Session 3: New (immuno)therapeutic strategies in lymphoma 

Chair: Jan M Zaucha (Poland)

  • New drugs for lymphoma
    Wojciech Jurczak (Poland)
  • Immunotherapy today and tomorrow for multiple myeloma
    Hermann Einsele (Germany)
  • T-cell lymphomas: Is there immunotherapy beyond ADC?
    Kate Cwynarski (United Kingdom)
  • In vivo CAR T-cell therapy
    Speaker to be announced  

15:30 – 16:00 Coffee break 

16:00 – 17:00 Panel discussion: Choosing between CAR T-cells and bispecific antibodies 

Panelists 

  • Wendy Osborne (United Kingdom)
  • Speaker to be announced
  • Speaker to be announced

17:00 – 18:00 Panel discussion: Availability and reimbursement issues 

Chair to be announced 

Panelists 

  • Jan M Zaucha (Poland)
  • Speaker to be announced
  • Speaker to be announced  

18:15 – 19:15 Oral Session 2

09:00 – 10:30 Session 4: Immunotherapy beyond lymphoma 

Chair: Hermann Einsele (Germany) 

  • Immunotherapy of other hematologic malignancies and non-malignant diseases
    Hermann Einsele (Germany)
  • Hostile lymphoma microenvironment and how to overcome it (in the elderly)
    Speaker to be announced
  • Non-infectious side-effects of immunotherapy (incl. secondary cancers)
    Judith Hecker (Germany)
  • Analyses and biomarkers on CAR & TCR products
    Speaker to be announced  

10:30 – 11:00 Coffee break  

11:00 – 11:45 Debate: New strategies and technologies for correlative research in immunotherapy 

Chair & speakers to be announced 

11:45 – 12:00 Closing remarks 

  • Igor Aurer (Croatia)
  • Hermann Einsele (Germany)
  • Raúl Córdoba (Spain)
Share